| abstract |
Formula I: The use of the compound as a calcium receptor activating compound for the prevention, treatment or alleviation of a physiological disorder or disease associated with abnormal CaSR activity, for example, hyperparathyroidism, a medicament containing the compound Compositions, methods of treating diseases with the compounds, and use of the compounds in the manufacture of a medicament. |